Role of Eplerenone in Reducing Recurrence of Atrial Fibrillation in Patient With Structural Heart Disease
Status:
Not yet recruiting
Trial end date:
2027-05-20
Target enrollment:
Participant gender:
Summary
The aim of this study is to study synergistic effect of eplerenone as Selective aldosterone
receptor antagonist with amiodarone compared with amiodarone only in reducing recurrence of
atrial fibrillation in patient with structural heart disease